Topical Drug Delivery Market

1. Topical Drug Delivery Market is thriving worldwide by 2029 The global topical drug delivery market is anticipated to grow at a considerable CAGR of 6.1% during the forecast period. The key factor contributing to the market growth includes the increasing approvals, grants, and clearance by government authorities and regulatory bodies for topical drugs. For instance, To Request a Sample of our Report on Topical Drug Delivery Market https://www.omrglobal.com/request-sample/topical-drug-delivery-market In July 2022, Alembic Pharmaceuticals, (Aleor Dermaceuticals) received the US Food and Drug Administration (US FDA) approval for its Abbreviated New Drug Application (ANDA) for Diclofenac Sodium Topical Gel. This newly approved drug is for the topical treatment of actinic keratoses and now it is a reference listed drug product (RLD) Solaraze Topical Gel, 3%. In July 2022, Arcutis Biotherapeutics, Inc. received approval by the US FDA for its New Drug Application (NDA) for ZORYVE (roflumilast) cream 0.3% that is used in the treatment of plaque psoriasis, including intertriginous areas. This newly approved drug offers rapid clearance of psoriasis plaques and reduces itching, and it is set to be available by mid of August 2022. In August 2020, LEO Pharma A/S, an investigational topical pan-Janus kinase (JAK)-inhibitor, a delgocitinib cream, has been granted Fast Track designation by the US FDA for the treatment of adults with moderate-to-severe chronic hand eczema (CHE). In June 2020, TDupixent (dupilumab) used for treating moderate-to- severe atopic dermatitis in adults has been approved by the National Medical Products Administration (NMPA) in China. It stated Dupixent as an overseas medicine and approval was based on positive data from the global LIBERTY AD clinical trial program and is medicine considered urgently needed in clinical practice. A full Report of Topical Drug Delivery Market https://www.omrglobal.com/industry-reports/topical-drug-delivery-market Market Coverage    The market number available for – 2021-2028 Base year- 2021 Forecast period- 2023-2029 Segment Covered-    By Product By Route of Administration By End-User Regions Covered-      North America Europe Asia-Pacific Rest of the World Competitive Landscape- AbbVie Inc., Glenmark Pharmaceuticals Ltd., Merck KGaA, Novartis International AG, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., and others. Key questions addressed by the report       What is the market growth rate? Which segment and region dominate the market in the base year? Which segment and region will project the fastest growth in the market? Who is the leader in the market? How players are addressing challenges to sustain growth? Where is the investment opportunity? Global Topical Drug Delivery Market Report Segment By Product Semi-Solid Formulations      Creams Ointments Lotions Gel Pastes Liquid Formulations   Suspensions Solutions Solid Formulations   Powders Suppositories Transdermal Products

2.   Transdermal Patches Transdermal Semi-Solids By Route of Administration      Dermal Drug Delivery Ophthalmic Drug Delivery Rectal Drug Delivery Vaginal Drug Delivery Nasal Drug Delivery By Facility of Use     Home Care Settings Hospitals & Clinics Burn Centers Other Facilities For More Customized Data, Request for Report Customization https://www.omrglobal.com/report-customization/topical-drug-delivery-market About Orion Market Research Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. Media Contact Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +91 780-304-0404